The pharmaceutical landscape for blood sugar is evolving, and transdermal GLP-1 delivery systems represent a exciting development. Unlike shots, this method offers a less invasive way to deliver GLP-1 drugs. These patches steadily release the medication through the epidermis offering a even dose of the beneficial agent, which can optimize glucos… Read More